Απάντηση αναφοράςΟ κωδικός ΕΣ/ΣΟ 300360 είναι εκτός πεδίου εφαρμογής για την προετοιμασία EUDR.
Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale Η ευρετηριασμένη μηχανή πεδίου εφαρμογής επιστρέφει Out of scope για αυτόν τον κωδικό. No Annex I scope match was found for this indexed CN code.
Βάση πεδίου εφαρμογήςΓιατί αυτή η σελίδα αναφοράς δίνει αυτή την απάντηση.
- Περιγραφή κωδικού
- Medicaments containing any of the following antimalarial active principles: artemisinin (INN) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (INN); artelinic acid or its salts; artenimol (INN); artemotil (INN); artemether (INN); artesunate (INN); chloroquine (INN); dihydroartemisinin (INN); lumefantrine (INN); mefloquine (INN); piperaquine (INN); pyrimethamine (INN) or sulfadoxine (INN), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail sale
- Βάση παραρτήματος I
- Καμία άμεση καταχώριση στο παράρτημα I
- Βάση πηγής
- Regulation (EU) 2023/1115 Annex I and CN 2026 index
Ιεραρχία ΣΟΓονικές, θυγατρικές και γειτονικές γραμμές.
Η προβολή βιβλιοθήκης προορίζεται για πλοήγηση αναφοράς. Χρησιμοποιήστε τον ελεγκτή όταν θέλετε να εκτελέσετε έναν άλλο κωδικό ως ενέργεια.
30φαρμακευτικα προϊονταout3003medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses, not in measured doses or put up for retail sale (excl. goods of heading 3002, 3005 or 3006)out30036000medicaments containing any of the following antimalarial active principles: artemisinin (inn) for oral ingestion combined with other pharmaceutical active ingredients, or amodiaquine (inn); artelinic acid or its salts; artenimol (inn); artemotil (inn); artemether (inn); artesunate (inn); chloroquine (inn); dihydroartemisinin (inn); lumefantrine (inn); mefloquine (inn); piperaquine (inn); pyrimethamine (inn) or sulfadoxine (inn), not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300310medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof, not in measured doses or put up for retail saleout300320medicaments containing antibiotics, not in measured doses or put up for retail sale (excl. medicaments containing penicillins or derivatives thereof with a penicillanic acid structure, or streptomycins or derivatives thereof)out300331medicaments containing insulin, not in measured doses or put up for retail saleout300339medicaments containing hormones or steroids used as hormones, not containing antibiotics, not in measured doses or put up for retail sale (excl. those containing insulin)out300340medicaments containing alkaloids or derivatives thereof, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout300341medicaments containing ephedrine or its salts, not containing hormones, steroids used as hormones or antibiotics, not in measured doses or put up for retail saleout Μοτίβο αποδεικτικών στοιχείωνΤι σημαίνει αυτό για την προετοιμασία.
Αυτή η γραμμή δεν ενεργοποιεί άμεσα τη συλλογή αποδεικτικών στοιχείων στο τρέχον αποτέλεσμα πεδίου εφαρμογής.